INMB - INmune Bio, Inc. Stock Analysis | Stock Taper

SCREENER COMPARE ANY 2 STOCKS

INMB

INMUNE BIO, INC.

NASDAQ

$2.32

▲ UP 7.41% (0.16)

KEY STATISTICS

Market Cap$61.68 M

52w High$2.38

52w Low$1.09

Dividend Yield—

Frequency—

P/E-3.46

Volume520.14K

Shares Out.26.59M

COMPANY

LEADERSHIP

David J. Moss

CHIEF EXECUTIVE

David J. Moss

COMPENSATION 2026

Salary$416,268

Stock Awards$1,428,911

Incentive Plan Pay$0

All Other Comp.$0

Total$1,845,179

ABOUT

SECTOR

Healthcare

WENT PUBLIC

February 4, 2019

METHOD OF GOING PUBLIC

IPO

FULL TIME EMPLOYEES

21

PRICE TARGET

Target High$22.00

Target Low$22.00

Target Median$22.00

Target Consensus$22.00

UPCOMING EARNINGS

DateOct 29, 2026

DayThursday

Rev. Est.$1.88M

OCT

29

THU

PRICE

$2.32 ▲ UP 7.41% (+$0.16)

About INmune Bio, Inc.

https://www.inmunebio.com ↗

INmune Bio, Inc. is a clinical-stage immunotherapy company developing drugs to reprogram the innate immune system for treating cancers, inflammation, and Alzheimer's, with programs like INKmune, INB03, and XPro1595.

INDUSTRY

Biotechnology

A PRODUCT INMUNE BIO, INC. IS KNOWN FOR

CORDStrom™

CORDStrom™

INmune Bio's leading cell-based therapy, derived from umbilical cord mesenchymal stromal cells, is in late-stage development and has completed Phase 3 trials for treating the severe genetic skin disorder RDEB.

COMPETITORS

COMPETITOR

ETFS HOLDING THIS STOCK

ETFS HOLDING

13

LISTED HERE

3

RANKED BY POSITION SIZE

0.00% · 490.3K

INSTITUTIONAL OWNERSHIP

SHARES OWNED

23.09%

HOLDERS

103

TOP 12 OF 103 · RANKED BY POSITION SIZE

Blackrock, Inc.

1.2M sh · $1.89M

Vanguard Group Inc

957.8K sh · $1.49M

812.9K sh · $7.17M

Cvi Holdings, LLC

596.4K sh · $5.26M

Geode Capital Management, LLC

495.0K sh · $559.46K

Raymond James Financial Services Advisors, Inc.

369.4K sh · $1.99M

State Street Corp

347.3K sh · $541.72K

Dauntless Investment Group, LLC

304.9K sh · $475.68K

Aqr Capital Management LLC

270.3K sh · $305.46K

Raymond James Financial Inc

268.5K sh · $555.71K

253.3K sh · $286.27K

Susquehanna International Group, Llp

250.9K sh · $391.42K

RATINGS SNAPSHOT

Overall rating: C+

Discounted Cash Flow3

Return On Equity1

Return On Assets1

Debt To Equity3

Price To Earnings1

Price To Book3

Overall Score2

INSIDER TRADES

★

DIRECTOR

Juda Scott

Purchase · 14.8K shares

2026-07-02

★

OFFICER: CHIEF SCIENTIFIC OFFICER

Lowdell Mark William

Purchase · 7.2K shares

2026-07-02

★

OFFICER: CHIEF SCIENTIFIC OFFICER

Lowdell Mark William

Sale · 7.2K shares

2026-07-02

★

DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER

Moss David J

Purchase · 9.0K shares

2026-07-02

MOST RECENT ANALYST GRADES

GRADE SUMMARY

BUY 1

1 GRADES IN THE LAST 12 MONTHS

LUCID CAPITAL MARKETS BUY

SECTORS PEERS

PEER	PRICE
XFOR	$4.04	COMPARE
OKUR	$3.94	COMPARE
ALGS	$6.67	COMPARE
BRNS	$0.62	COMPARE
TPST	$1.04	COMPARE
PDSB	$0.22	COMPARE
SKYE	$0.28	COMPARE